Patterns of medical management of overactive bladder (OAB) and benign prostatic hyperplasia (BPH) in the United States.

Persistence was higher with BPH than OAB medications overall, whereas switching rates were higher in the OAB group. The lower persistence of OAB medication may be due to less efficacy or tolerability. The possibility of under treatment of OAB also warrants future investigations.